pharma-and-clinical-pharmacy-congress-2016

Notes:

Page 41

Pharma & Clinical Pharmacy Congress 2016

November 07-09, 2016

Volume 5 Issue 4(Suppl)

Clin Pharmacol Biopharm

ISSN: 2167-065X CPB, an open access journal

conferenceseries

.com

November 07-09, 2016 Las Vegas, Nevada, USA

International

Pharma & Clinical Pharmacy Congress

Mervat Alsous et al., Clin Pharmacol Biopharm 2016, 5:4(Suppl)

Depression among patients with diabetic foot in Jordan

Mervat Alsous

, Feras Darwish Elhajji

, Ghada Abu Amara

, Eman Elayeh

, Amal Akour

and Ayman Mismar

Applied Science University, Jordan

University of Jordan, Jordan

Objectives:

The aims of this studywere toassess depressive symptoms inpatientswithdiabetic foot using center for epidemiologic

studies depression scale (CES-D) and investigate the association between depressive symptoms and characteristics of patients

with diabetic foot.

Methods:

A sample of 108 patients with diabetic foot was recruited from May 2015-November 2015. The center (CES-D) was

used to assess risk for depression among patients using cut-off score ≥27. Patients’ demographic data and medical history were

collected using pre-structured forms.

Results:

Of the entire sample, 38.9% have risk for major depression according to CES-D score. Univariate analyses showed

that age, gender, income, duration of DM were not associated with an increase in risk for major depression among patients

with diabetic foot. On the other hand according to logistic regression analysis, retinopathy were significantly associated

with increased depressive symptoms among diabetic foot patients (odds ratio 3.41(p=0.017). Being on a combination of oral

hypoglycemic agents and insulin treatment was significantly associated with lower depressive symptoms (odds ratio 3.38

(p=0.022). Patients with primary education level have the highest odds ratio among all factors associated with risk for major

depression (OR, 4.07; p=0.003).

Conclusion:

The risk for major depression among patients with diabetic foot in Jordan is high compared to general diabetic

population. This was associated with low educational level, retinopathy, and not taking combination of oral hypoglycemic

agents and insulin. There is a need for routine screening for depression in patients with diabetic foot to help in the prevention,

early detection of depression and even referral to a psychiatrist.